+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
DNA Modifying Agents Market - Global Forecast 2026-2032- Product Image
DNA Modifying Agents Market - Global Forecast 2026-2032- Product Image
Sale

DNA Modifying Agents Market - Global Forecast 2026-2032

  • Report

  • 189 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6149419
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The DNA Modifying Agents Market is projected to reach USD 1.73 Billion in 2026. It is expected to continue growing at a CAGR of 7.05%, reaching USD 2.61 Billion by 2032.

DNA-Modifying Agents: Executive Overview

DNA-modifying agents encompass technologies and therapeutic approaches that alter, repair, silence, replace, or otherwise influence genetic material. Their development spans genome editing, gene regulation, DNA repair, epigenetic modulation, and nucleic-acid delivery. Progress is shaped by biological validation, delivery performance, manufacturing consistency, clinical evidence, and evolving standards for safety and patient selection.

Platform Convergence Is Reshaping DNA Modification

The landscape is shifting from isolated editing tools toward integrated platforms that combine target design, delivery systems, biomarker development, and longitudinal monitoring. Precision has improved through better guide design, engineered enzymes, and tissue-specific delivery, while advances in manufacturing are supporting more reproducible production of complex products. At the same time, regulators and healthcare systems are placing greater emphasis on durability, off-target assessment, immunogenicity, long-term follow-up, and equitable access.

Artificial Intelligence Accelerates Design, Validation, and Operations

Artificial intelligence is influencing DNA-modifying agents across the development cycle. Machine-learning models can prioritize targets, predict guide activity and off-target interactions, characterize sequence-function relationships, and support interpretation of multi-omics data. AI also contributes to process optimization, quality control, patient stratification, and safety surveillance. Its value depends on representative datasets, experimental validation, explainability, cybersecurity, and governance that prevents model outputs from being treated as clinical evidence without confirmation.

Regional Insights: Regulation, Infrastructure, and Access Diverge

North America combines advanced research capacity, specialized manufacturing, and established regulatory pathways, but faces cost, reimbursement, and long-term monitoring challenges. Europe benefits from strong translational science and coordinated standards, while differences among national health systems can complicate adoption. Asia-Pacific is advancing through substantial research investment, growing biomanufacturing capabilities, and expanding clinical infrastructure. Latin America is building capacity unevenly, with access influenced by specialized centers, regulatory maturity, and public-health priorities. The Middle East is investing in precision medicine and biotechnology hubs, while workforce development and evidence-generation capacity remain important. Africa has significant unmet medical needs and emerging genomic initiatives, but infrastructure, financing, sample governance, and specialist availability remain central constraints.

Group Insights: Cooperation Shapes Scientific and Regulatory Capacity

ASEAN countries are developing varied capabilities in genomics, clinical research, and advanced manufacturing, creating opportunities for regional knowledge-sharing and harmonized oversight. BRICS members contribute large patient populations, research assets, and manufacturing potential, although regulatory systems and infrastructure differ substantially. The European Union benefits from cross-border research and common regulatory structures while retaining national variation in reimbursement and implementation. G7 economies generally possess deep scientific, clinical, and manufacturing capabilities, alongside demanding evidence and safety expectations. GCC countries are strengthening precision-medicine infrastructure and investment capacity, with continued needs in specialist training and data integration. NATO members span mature and developing biomedical ecosystems, making interoperability, research collaboration, and secure data governance important considerations.

Country Insights: National Capabilities and Policy Priorities Differ

Australia supports genomics research and specialized clinical programs, with geography and access shaping implementation. Brazil is expanding biotechnology and genomic capacity while managing regional disparities and complex regulatory needs. Canada combines strong academic research with publicly oriented healthcare considerations. China has substantial research, manufacturing, and clinical capabilities, alongside stringent requirements for governance and translation. France, Germany, Italy, and Spain contribute established biomedical research and healthcare systems, but adoption may vary with national assessment and reimbursement processes. India offers large-scale clinical and scientific capabilities, with affordability, quality systems, and access remaining important. Japan emphasizes advanced biomedical research, rigorous evaluation, and long-term safety. Mexico is developing genomic and biotechnology infrastructure amid uneven access. Russia retains scientific capabilities but faces constraints related to collaboration, supply chains, and access to advanced technologies. South Korea is strengthening precision medicine, biomanufacturing, and digital health integration. The United Kingdom benefits from strong genomic research and regulatory expertise, while implementation depends on evidence and health-system adoption. The United States has extensive research, clinical, manufacturing, and investment capacity, with scrutiny focused on safety, durability, reimbursement, and equitable access.

Action Priorities for Leaders in DNA-Modifying Agents

Industry leaders should establish evidence strategies that address target validation, delivery, off-target effects, immunogenicity, durability, and patient selection from the outset. They should build platform capabilities around modular manufacturing, validated analytical methods, secure data systems, and scalable quality controls. Partnerships with clinical centers, diagnostic developers, regulators, payers, and patient communities can improve trial design and implementation readiness. Leaders should also use AI with documented validation, human oversight, bias testing, and clear audit trails. Finally, regional access plans should account for specialist training, cold-chain or logistical requirements, long-term follow-up, affordability, and responsible genomic-data stewardship.

Research Methodology for the Executive Summary

This executive summary uses a qualitative synthesis of established scientific, clinical, regulatory, manufacturing, and health-system considerations relevant to DNA-modifying agents. The assessment organizes implications across six specified regions, six multinational groups, and fifteen countries, emphasizing differences in research capacity, infrastructure, governance, access, and implementation conditions. It avoids market estimation and relies on verifiable domain-level observations rather than unsupported numerical claims. Conclusions should be supplemented with current regulatory documents, peer-reviewed evidence, clinical-trial records, manufacturing standards, and country-specific health-technology assessments before strategic decisions are made.

Conclusion: Durable Progress Requires Integrated Evidence and Access Planning

DNA-modifying agents are advancing through convergence among genome science, delivery engineering, computational methods, diagnostics, and biomanufacturing. The principal opportunities are substantial, but translation depends on reliable safety assessment, durable clinical benefit, robust production, appropriate regulation, and practical delivery through health systems. Organizations that integrate scientific rigor with regional partnerships, responsible AI, long-term monitoring, and equitable access planning will be better positioned to convert technical progress into sustainable patient and public-health value.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. DNA Modifying Agents Market, by Technology
7.1. Introduction
7.2. Crispr Cas Systems
7.3. Meganucleases
7.4. Talens
7.5. Zinc Finger Nucleases
8. DNA Modifying Agents Market, by Application
8.1. Introduction
8.2. Agriculture And Animal Biotechnology
8.2.1. Animal Health
8.2.2. Crop Improvement
8.3. Industrial Biotechnology
8.3.1. Biocatalysts
8.3.2. Biofuels
8.3.3. Biopolymers
8.4. Research And Diagnostics
8.4.1. Diagnostic Tools
8.4.2. In Vitro Research
8.5. Therapeutic Development
8.5.1. Genetic Disorders
8.5.2. Infectious Diseases
8.5.3. Oncology
9. DNA Modifying Agents Market, by End User
9.1. Introduction
9.2. Academic And Research Institutions
9.3. Agricultural Companies
9.4. Bio Pharmaceutical Companies
9.5. Contract Research Organizations
10. DNA Modifying Agents Market, by Region
10.1. Introduction
10.2. Asia-Pacific
10.3. North America
10.4. Latin America
10.5. Europe
10.6. Middle East
10.7. Africa
11. DNA Modifying Agents Market, by Group
11.1. Introduction
11.2. ASEAN
11.3. GCC
11.4. European Union
11.5. BRICS
11.6. G7
11.7. NATO
12. DNA Modifying Agents Market, by Country
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. United Kingdom
12.7. Germany
12.8. France
12.9. Russia
12.10. Italy
12.11. Spain
12.12. China
12.13. India
12.14. Japan
12.15. Australia
12.16. South Korea
13. Competitive Landscape
13.1. Market Share Analysis, 2025
13.2. Market Concentration Analysis, 2025
13.2.1. Concentration Ratio (CR)
13.2.2. Herfindahl Hirschman Index (HHI)
13.3. Recent Developments & Impact Analysis, 2025
13.4. Product Portfolio Analysis, 2025
13.5. Benchmarking Analysis, 2025
14. Company Profiles
14.1. Agilent Technologies, Inc.
14.2. Applied Biosystems
14.3. Bio-Rad Laboratories, Inc.
14.4. Caribou Biosciences, Inc.
14.5. Cellectis SA
14.6. CRISPR Therapeutics AG
14.7. Editas Medicine, Inc.
14.8. GenScript Biotech Corporation
14.9. Integrated DNA Technologies, Inc.
14.10. Intellia Therapeutics, Inc.
14.11. Lonza Group AG
14.12. Merck & Co., Inc.
14.13. Merck Group
14.14. New England Biolabs, Inc.
14.15. Roche Holding AG
14.16. Sangamo Therapeutics, Inc.
14.17. Takara Bio Inc.
14.18. Thermo Fisher Scientific Inc.
14.19. Zymo Research Corporation
15. Key Experts
LIST OF FIGURES
FIGURE 1. Global DNA Modifying Agents Market, Years Considered for the Study
FIGURE 2. Global DNA Modifying Agents Market, Research Design
FIGURE 3. Global DNA Modifying Agents Market, Research Framework
FIGURE 4. Global DNA Modifying Agents Market, Data Triangulation
FIGURE 5. Global DNA Modifying Agents Market Size, 2017-2032 (USD Million)
FIGURE 6. Global DNA Modifying Agents Market Size, by Technology, 2025 vs 2032 (%)
FIGURE 7. Global DNA Modifying Agents Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global DNA Modifying Agents Market Size, by Application, 2025 vs 2032 (%)
FIGURE 9. Global DNA Modifying Agents Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global DNA Modifying Agents Market Size, by End User, 2025 vs 2032 (%)
FIGURE 11. Global DNA Modifying Agents Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global DNA Modifying Agents Market Size, by Region, 2025 vs 2032 (%)
FIGURE 13. Global DNA Modifying Agents Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global DNA Modifying Agents Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 15. Global DNA Modifying Agents Market Size, by Country, 2025 vs 2032 (%)
FIGURE 16. Global DNA Modifying Agents Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global DNA Modifying Agents Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global DNA Modifying Agents Market Segmentation & Coverage
TABLE 2. Global DNA Modifying Agents Market Size, 2017-2032 (USD Million)
TABLE 3. Global DNA Modifying Agents Market Size, by Technology, 2017-2032 (USD Million)
TABLE 4. Global Crispr Cas Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Crispr Cas Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Crispr Cas Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Meganucleases Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Meganucleases Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Meganucleases Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Talens Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Talens Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Talens Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Zinc Finger Nucleases Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Zinc Finger Nucleases Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Zinc Finger Nucleases Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global DNA Modifying Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 17. Global Agriculture And Animal Biotechnology Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Agriculture And Animal Biotechnology Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Agriculture And Animal Biotechnology Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Animal Health Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Animal Health Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Animal Health Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Crop Improvement Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Crop Improvement Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Crop Improvement Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Industrial Biotechnology Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Industrial Biotechnology Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Industrial Biotechnology Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Biocatalysts Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Biocatalysts Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Biocatalysts Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Biofuels Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Biofuels Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Biofuels Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global Biopolymers Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global Biopolymers Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global Biopolymers Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global Research And Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global Research And Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global Research And Diagnostics Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Diagnostic Tools Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Diagnostic Tools Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Diagnostic Tools Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global In Vitro Research Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global In Vitro Research Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global In Vitro Research Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Therapeutic Development Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Therapeutic Development Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Therapeutic Development Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Genetic Disorders Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Genetic Disorders Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Genetic Disorders Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Infectious Diseases Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Infectious Diseases Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Infectious Diseases Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Oncology Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Oncology Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Oncology Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global DNA Modifying Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 60. Global Academic And Research Institutions Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Global Academic And Research Institutions Market Size, by Group, 2017-2032 (USD Million)
TABLE 62. Global Academic And Research Institutions Market Size, by Country, 2017-2032 (USD Million)
TABLE 63. Global Agricultural Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. Global Agricultural Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 65. Global Agricultural Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 66. Global Bio Pharmaceutical Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Global Bio Pharmaceutical Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 68. Global Bio Pharmaceutical Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 69. Global Contract Research Organizations Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. Global Contract Research Organizations Market Size, by Group, 2017-2032 (USD Million)
TABLE 71. Global Contract Research Organizations Market Size, by Country, 2017-2032 (USD Million)
TABLE 72. Global DNA Modifying Agents Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Asia-Pacific DNA Modifying Agents Market Size, by Region, 2017-2032 (USD Million)
TABLE 74. Asia-Pacific DNA Modifying Agents Market Size, by Technology, 2017-2032 (USD Million)
TABLE 75. Asia-Pacific DNA Modifying Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 76. Asia-Pacific DNA Modifying Agents Market Size, by Agriculture And Animal Biotechnology, 2017-2032 (USD Million)
TABLE 77. Asia-Pacific DNA Modifying Agents Market Size, by Industrial Biotechnology, 2017-2032 (USD Million)
TABLE 78. Asia-Pacific DNA Modifying Agents Market Size, by Research And Diagnostics, 2017-2032 (USD Million)
TABLE 79. Asia-Pacific DNA Modifying Agents Market Size, by Therapeutic Development, 2017-2032 (USD Million)
TABLE 80. Asia-Pacific DNA Modifying Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 81. North America DNA Modifying Agents Market Size, by Region, 2017-2032 (USD Million)
TABLE 82. North America DNA Modifying Agents Market Size, by Technology, 2017-2032 (USD Million)
TABLE 83. North America DNA Modifying Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 84. North America DNA Modifying Agents Market Size, by Agriculture And Animal Biotechnology, 2017-2032 (USD Million)
TABLE 85. North America DNA Modifying Agents Market Size, by Industrial Biotechnology, 2017-2032 (USD Million)
TABLE 86. North America DNA Modifying Agents Market Size, by Research And Diagnostics, 2017-2032 (USD Million)
TABLE 87. North America DNA Modifying Agents Market Size, by Therapeutic Development, 2017-2032 (USD Million)
TABLE 88. North America DNA Modifying Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 89. Latin America DNA Modifying Agents Market Size, by Region, 2017-2032 (USD Million)
TABLE 90. Latin America DNA Modifying Agents Market Size, by Technology, 2017-2032 (USD Million)
TABLE 91. Latin America DNA Modifying Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 92. Latin America DNA Modifying Agents Market Size, by Agriculture And Animal Biotechnology, 2017-2032 (USD Million)
TABLE 93. Latin America DNA Modifying Agents Market Size, by Industrial Biotechnology, 2017-2032 (USD Million)
TABLE 94. Latin America DNA Modifying Agents Market Size, by Research And Diagnostics, 2017-2032 (USD Million)
TABLE 95. Latin America DNA Modifying Agents Market Size, by Therapeutic Development, 2017-2032 (USD Million)
TABLE 96. Latin America DNA Modifying Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 97. Europe DNA Modifying Agents Market Size, by Region, 2017-2032 (USD Million)
TABLE 98. Europe DNA Modifying Agents Market Size, by Technology, 2017-2032 (USD Million)
TABLE 99. Europe DNA Modifying Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 100. Europe DNA Modifying Agents Market Size, by Agriculture And Animal Biotechnology, 2017-2032 (USD Million)
TABLE 101. Europe DNA Modifying Agents Market Size, by Industrial Biotechnology, 2017-2032 (USD Million)
TABLE 102. Europe DNA Modifying Agents Market Size, by Research And Diagnostics, 2017-2032 (USD Million)
TABLE 103. Europe DNA Modifying Agents Market Size, by Therapeutic Development, 2017-2032 (USD Million)
TABLE 104. Europe DNA Modifying Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 105. Middle East DNA Modifying Agents Market Size, by Region, 2017-2032 (USD Million)
TABLE 106. Middle East DNA Modifying Agents Market Size, by Technology, 2017-2032 (USD Million)
TABLE 107. Middle East DNA Modifying Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 108. Middle East DNA Modifying Agents Market Size, by Agriculture And Animal Biotechnology, 2017-2032 (USD Million)
TABLE 109. Middle East DNA Modifying Agents Market Size, by Industrial Biotechnology, 2017-2032 (USD Million)
TABLE 110. Middle East DNA Modifying Agents Market Size, by Research And Diagnostics, 2017-2032 (USD Million)
TABLE 111. Middle East DNA Modifying Agents Market Size, by Therapeutic Development, 2017-2032 (USD Million)
TABLE 112. Middle East DNA Modifying Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 113. Africa DNA Modifying Agents Market Size, by Region, 2017-2032 (USD Million)
TABLE 114. Africa DNA Modifying Agents Market Size, by Technology, 2017-2032 (USD Million)
TABLE 115. Africa DNA Modifying Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 116. Africa DNA Modifying Agents Market Size, by Agriculture And Animal Biotechnology, 2017-2032 (USD Million)
TABLE 117. Africa DNA Modifying Agents Market Size, by Industrial Biotechnology, 2017-2032 (USD Million)
TABLE 118. Africa DNA Modifying Agents Market Size, by Research And Diagnostics, 2017-2032 (USD Million)
TABLE 119. Africa DNA Modifying Agents Market Size, by Therapeutic Development, 2017-2032 (USD Million)
TABLE 120. Africa DNA Modifying Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 121. Global DNA Modifying Agents Market Size, by Group, 2017-2032 (USD Million)
TABLE 122. ASEAN DNA Modifying Agents Market Size, by Group, 2017-2032 (USD Million)
TABLE 123. ASEAN DNA Modifying Agents Market Size, by Technology, 2017-2032 (USD Million)
TABLE 124. ASEAN DNA Modifying Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 125. ASEAN DNA Modifying Agents Market Size, by Agriculture And Animal Biotechnology, 2017-2032 (USD Million)
TABLE 126. ASEAN DNA Modifying Agents Market Size, by Industrial Biotechnology, 2017-2032 (USD Million)
TABLE 127. ASEAN DNA Modifying Agents Market Size, by Research And Diagnostics, 2017-2032 (USD Million)
TABLE 128. ASEAN DNA Modifying Agents Market Size, by Therapeutic Development, 2017-2032 (USD Million)
TABLE 129. ASEAN DNA Modifying Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 130. GCC DNA Modifying Agents Market Size, by Group, 2017-2032 (USD Million)
TABLE 131. GCC DNA Modifying Agents Market Size, by Technology, 2017-2032 (USD Million)
TABLE 132. GCC DNA Modifying Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 133. GCC DNA Modifying Agents Market Size, by Agriculture And Animal Biotechnology, 2017-2032 (USD Million)
TABLE 134. GCC DNA Modifying Agents Market Size, by Industrial Biotechnology, 2017-2032 (USD Million)
TABLE 135. GCC DNA Modifying Agents Market Size, by Research And Diagnostics, 2017-2032 (USD Million)
TABLE 136. GCC DNA Modifying Agents Market Size, by Therapeutic Development, 2017-2032 (USD Million)
TABLE 137. GCC DNA Modifying Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 138. European Union DNA Modifying Agents Market Size, by Group, 2017-2032 (USD Million)
TABLE 139. European Union DNA Modifying Agents Market Size, by Technology, 2017-2032 (USD Million)
TABLE 140. European Union DNA Modifying Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 141. European Union DNA Modifying Agents Market Size, by Agriculture And Animal Biotechnology, 2017-2032 (USD Million)
TABLE 142. European Union DNA Modifying Agents Market Size, by Industrial Biotechnology, 2017-2032 (USD Million)
TABLE 143. European Union DNA Modifying Agents Market Size, by Research And Diagnostics, 2017-2032 (USD Million)
TABLE 144. European Union DNA Modifying Agents Market Size, by Therapeutic Development, 2017-2032 (USD Million)
TABLE 145. European Union DNA Modifying Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 146. BRICS DNA Modifying Agents Market Size, by Group, 2017-2032 (USD Million)
TABLE 147. BRICS DNA Modifying Agents Market Size, by Technology, 2017-2032 (USD Million)
TABLE 148. BRICS DNA Modifying Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 149. BRICS DNA Modifying Agents Market Size, by Agriculture And Animal Biotechnology, 2017-2032 (USD Million)
TABLE 150. BRICS DNA Modifying Agents Market Size, by Industrial Biotechnology, 2017-2032 (USD Million)
TABLE 151. BRICS DNA Modifying Agents Market Size, by Research And Diagnostics, 2017-2032 (USD Million)
TABLE 152. BRICS DNA Modifying Agents Market Size, by Therapeutic Development, 2017-2032 (USD Million)
TABLE 153. BRICS DNA Modifying Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 154. G7 DNA Modifying Agents Market Size, by Group, 2017-2032 (USD Million)
TABLE 155. G7 DNA Modifying Agents Market Size, by Technology, 2017-2032 (USD Million)
TABLE 156. G7 DNA Modifying Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 157. G7 DNA Modifying Agents Market Size, by Agriculture And Animal Biotechnology, 2017-2032 (USD Million)
TABLE 158. G7 DNA Modifying Agents Market Size, by Industrial Biotechnology, 2017-2032 (USD Million)
TABLE 159. G7 DNA Modifying Agents Market Size, by Research And Diagnostics, 2017-2032 (USD Million)
TABLE 160. G7 DNA Modifying Agents Market Size, by Therapeutic Development, 2017-2032 (USD Million)
TABLE 161. G7 DNA Modifying Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 162. NATO DNA Modifying Agents Market Size, by Group, 2017-2032 (USD Million)
TABLE 163. NATO DNA Modifying Agents Market Size, by Technology, 2017-2032 (USD Million)
TABLE 164. NATO DNA Modifying Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 165. NATO DNA Modifying Agents Market Size, by Agriculture And Animal Biotechnology, 2017-2032 (USD Million)
TABLE 166. NATO DNA Modifying Agents Market Size, by Industrial Biotechnology, 2017-2032 (USD Million)
TABLE 167. NATO DNA Modifying Agents Market Size, by Research And Diagnostics, 2017-2032 (USD Million)
TABLE 168. NATO DNA Modifying Agents Market Size, by Therapeutic Development, 2017-2032 (USD Million)
TABLE 169. NATO DNA Modifying Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 170. Global DNA Modifying Agents Market Size, by Country, 2017-2032 (USD Million)
TABLE 171. United States DNA Modifying Agents Market Size, 2017-2032 (USD Million)
TABLE 172. United States DNA Modifying Agents Market Size, by Technology, 2017-2032 (USD Million)
TABLE 173. United States DNA Modifying Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 174. United States DNA Modifying Agents Market Size, by Agriculture And Animal Biotechnology, 2017-2032 (USD Million)
TABLE 175. United States DNA Modifying Agents Market Size, by Industrial Biotechnology, 2017-2032 (USD Million)
TABLE 176. United States DNA Modifying Agents Market Size, by Research And Diagnostics, 2017-2032 (USD Million)
TABLE 177. United States DNA Modifying Agents Market Size, by Therapeutic Development, 2017-2032 (USD Million)
TABLE 178. United States DNA Modifying Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 179. Canada DNA Modifying Agents Market Size, 2017-2032 (USD Million)
TABLE 180. Canada DNA Modifying Agents Market Size, by Technology, 2017-2032 (USD Million)
TABLE 181. Canada DNA Modifying Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 182. Canada DNA Modifying Agents Market Size, by Agriculture And Animal Biotechnology, 2017-2032 (USD Million)
TABLE 183. Canada DNA Modifying Agents Market Size, by Industrial Biotechnology, 2017-2032 (USD Million)
TABLE 184. Canada DNA Modifying Agents Market Size, by Research And Diagnostics, 2017-2032 (USD Million)
TABLE 185. Canada DNA Modifying Agents Market Size, by Therapeutic Development, 2017-2032 (USD Million)
TABLE 186. Canada DNA Modifying Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 187. Mexico DNA Modifying Agents Market Size, 2017-2032 (USD Million)
TABLE 188. Mexico DNA Modifying Agents Market Size, by Technology, 2017-2032 (USD Million)
TABLE 189. Mexico DNA Modifying Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 190. Mexico DNA Modifying Agents Market Size, by Agriculture And Animal Biotechnology, 2017-2032 (USD Million)
TABLE 191. Mexico DNA Modifying Agents Market Size, by Industrial Biotechnology, 2017-2032 (USD Million)
TABLE 192. Mexico DNA Modifying Agents Market Size, by Research And Diagnostics, 2017-2032 (USD Million)
TABLE 193. Mexico DNA Modifying Agents Market Size, by Therapeutic Development, 2017-2032 (USD Million)
TABLE 194. Mexico DNA Modifying Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 195. Brazil DNA Modifying Agents Market Size, 2017-2032 (USD Million)
TABLE 196. Brazil DNA Modifying Agents Market Size, by Technology, 2017-2032 (USD Million)
TABLE 197. Brazil DNA Modifying Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 198. Brazil DNA Modifying Agents Market Size, by Agriculture And Animal Biotechnology, 2017-2032 (USD Million)
TABLE 199. Brazil DNA Modifying Agents Market Size, by Industrial Biotechnology, 2017-2032 (USD Million)
TABLE 200. Brazil DNA Modifying Agents Market Size, by Research And Diagnostics, 2017-2032 (USD Million)
TABLE 201. Brazil DNA Modifying Agents Market Size, by Therapeutic Development, 2017-2032 (USD Million)
TABLE 202. Brazil DNA Modifying Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 203. United Kingdom DNA Modifying Agents Market Size, 2017-2032 (USD Million)
TABLE 204. United Kingdom DNA Modifying Agents Market Size, by Technology, 2017-2032 (USD Million)
TABLE 205. United Kingdom DNA Modifying Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 206. United Kingdom DNA Modifying Agents Market Size, by Agriculture And Animal Biotechnology, 2017-2032 (USD Million)
TABLE 207. United Kingdom DNA Modifying Agents Market Size, by Industrial Biotechnology, 2017-2032 (USD Million)
TABLE 208. United Kingdom DNA Modifying Agents Market Size, by Research And Diagnostics, 2017-2032 (USD Million)
TABLE 209. United Kingdom DNA Modifying Agents Market Size, by Therapeutic Development, 2017-2032 (USD Million)
TABLE 210. United Kingdom DNA Modifying Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 211. Germany DNA Modifying Agents Market Size, 2017-2032 (USD Million)
TABLE 212. Germany DNA Modifying Agents Market Size, by Technology, 2017-2032 (USD Million)
TABLE 213. Germany DNA Modifying Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 214. Germany DNA Modifying Agents Market Size, by Agriculture And Animal Biotechnology, 2017-2032 (USD Million)
TABLE 215. Germany DNA Modifying Agents Market Size, by Industrial Biotechnology, 2017-2032 (USD Million)
TABLE 216. Germany DNA Modifying Agents Market Size, by Research And Diagnostics, 2017-2032 (USD Million)
TABLE 217. Germany DNA Modifying Agents Market Size, by Therapeutic Development, 2017-2032 (USD Million)
TABLE 218. Germany DNA Modifying Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 219. France DNA Modifying Agents Market Size, 2017-2032 (USD Million)
TABLE 220. France DNA Modifying Agents Market Size, by Technology, 2017-2032 (USD Million)
TABLE 221. France DNA Modifying Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 222. France DNA Modifying Agents Market Size, by Agriculture And Animal Biotechnology, 2017-2032 (USD Million)
TABLE 223. France DNA Modifying Agents Market Size, by Industrial Biotechnology, 2017-2032 (USD Million)
TABLE 224. France DNA Modifying Agents Market Size, by Research And Diagnostics, 2017-2032 (USD Million)
TABLE 225. France DNA Modifying Agents Market Size, by Therapeutic Development, 2017-2032 (USD Million)
TABLE 226. France DNA Modifying Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 227. Russia DNA Modifying Agents Market Size, 2017-2032 (USD Million)
TABLE 228. Russia DNA Modifying Agents Market Size, by Technology, 2017-2032 (USD Million)
TABLE 229. Russia DNA Modifying Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 230. Russia DNA Modifying Agents Market Size, by Agriculture And Animal Biotechnology, 2017-2032 (USD Million)
TABLE 231. Russia DNA Modifying Agents Market Size, by Industrial Biotechnology, 2017-2032 (USD Million)
TABLE 232. Russia DNA Modifying Agents Market Size, by Research And Diagnostics, 2017-2032 (USD Million)
TABLE 233. Russia DNA Modifying Agents Market Size, by Therapeutic Development, 2017-2032 (USD Million)
TABLE 234. Russia DNA Modifying Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 235. Italy DNA Modifying Agents Market Size, 2017-2032 (USD Million)
TABLE 236. Italy DNA Modifying Agents Market Size, by Technology, 2017-2032 (USD Million)
TABLE 237. Italy DNA Modifying Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 238. Italy DNA Modifying Agents Market Size, by Agriculture And Animal Biotechnology, 2017-2032 (USD Million)
TABLE 239. Italy DNA Modifying Agents Market Size, by Industrial Biotechnology, 2017-2032 (USD Million)
TABLE 240. Italy DNA Modifying Agents Market Size, by Research And Diagnostics, 2017-2032 (USD Million)
TABLE 241. Italy DNA Modifying Agents Market Size, by Therapeutic Development, 2017-2032 (USD Million)
TABLE 242. Italy DNA Modifying Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 243. Spain DNA Modifying Agents Market Size, 2017-2032 (USD Million)
TABLE 244. Spain DNA Modifying Agents Market Size, by Technology, 2017-2032 (USD Million)
TABLE 245. Spain DNA Modifying Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 246. Spain DNA Modifying Agents Market Size, by Agriculture And Animal Biotechnology, 2017-2032 (USD Million)
TABLE 247. Spain DNA Modifying Agents Market Size, by Industrial Biotechnology, 2017-2032 (USD Million)
TABLE 248. Spain DNA Modifying Agents Market Size, by Research And Diagnostics, 2017-2032 (USD Million)
TABLE 249. Spain DNA Modifying Agents Market Size, by Therapeutic Development, 2017-2032 (USD Million)
TABLE 250. Spain DNA Modifying Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 251. China DNA Modifying Agents Market Size, 2017-2032 (USD Million)
TABLE 252. China DNA Modifying Agents Market Size, by Technology, 2017-2032 (USD Million)
TABLE 253. China DNA Modifying Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 254. China DNA Modifying Agents Market Size, by Agriculture And Animal Biotechnology, 2017-2032 (USD Million)
TABLE 255. China DNA Modifying Agents Market Size, by Industrial Biotechnology, 2017-2032 (USD Million)
TABLE 256. China DNA Modifying Agents Market Size, by Research And Diagnostics, 2017-2032 (USD Million)
TABLE 257. China DNA Modifying Agents Market Size, by Therapeutic Development, 2017-2032 (USD Million)
TABLE 258. China DNA Modifying Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 259. India DNA Modifying Agents Market Size, 2017-2032 (USD Million)
TABLE 260. India DNA Modifying Agents Market Size, by Technology, 2017-2032 (USD Million)
TABLE 261. India DNA Modifying Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 262. India DNA Modifying Agents Market Size, by Agriculture And Animal Biotechnology, 2017-2032 (USD Million)
TABLE 263. India DNA Modifying Agents Market Size, by Industrial Biotechnology, 2017-2032 (USD Million)
TABLE 264. India DNA Modifying Agents Market Size, by Research And Diagnostics, 2017-2032 (USD Million)
TABLE 265. India DNA Modifying Agents Market Size, by Therapeutic Development, 2017-2032 (USD Million)
TABLE 266. India DNA Modifying Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 267. Japan DNA Modifying Agents Market Size, 2017-2032 (USD Million)
TABLE 268. Japan DNA Modifying Agents Market Size, by Technology, 2017-2032 (USD Million)
TABLE 269. Japan DNA Modifying Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 270. Japan DNA Modifying Agents Market Size, by Agriculture And Animal Biotechnology, 2017-2032 (USD Million)
TABLE 271. Japan DNA Modifying Agents Market Size, by Industrial Biotechnology, 2017-2032 (USD Million)
TABLE 272. Japan DNA Modifying Agents Market Size, by Research And Diagnostics, 2017-2032 (USD Million)
TABLE 273. Japan DNA Modifying Agents Market Size, by Therapeutic Development, 2017-2032 (USD Million)
TABLE 274. Japan DNA Modifying Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 275. Australia DNA Modifying Agents Market Size, 2017-2032 (USD Million)
TABLE 276. Australia DNA Modifying Agents Market Size, by Technology, 2017-2032 (USD Million)
TABLE 277. Australia DNA Modifying Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 278. Australia DNA Modifying Agents Market Size, by Agriculture And Animal Biotechnology, 2017-2032 (USD Million)
TABLE 279. Australia DNA Modifying Agents Market Size, by Industrial Biotechnology, 2017-2032 (USD Million)
TABLE 280. Australia DNA Modifying Agents Market Size, by Research And Diagnostics, 2017-2032 (USD Million)
TABLE 281. Australia DNA Modifying Agents Market Size, by Therapeutic Development, 2017-2032 (USD Million)
TABLE 282. Australia DNA Modifying Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 283. South Korea DNA Modifying Agents Market Size, 2017-2032 (USD Million)
TABLE 284. South Korea DNA Modifying Agents Market Size, by Technology, 2017-2032 (USD Million)
TABLE 285. South Korea DNA Modifying Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 286. South Korea DNA Modifying Agents Market Size, by Agriculture And Animal Biotechnology, 2017-2032 (USD Million)
TABLE 287. South Korea DNA Modifying Agents Market Size, by Industrial Biotechnology, 2017-2032 (USD Million)
TABLE 288. South Korea DNA Modifying Agents Market Size, by Research And Diagnostics, 2017-2032 (USD Million)
TABLE 289. South Korea DNA Modifying Agents Market Size, by Therapeutic Development, 2017-2032 (USD Million)
TABLE 290. South Korea DNA Modifying Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 291. Global DNA Modifying Agents Market Share, by Key Player, 2025
TABLE 292. Global DNA Modifying Agents Market, Key Experts

Companies Mentioned

  • Agilent Technologies, Inc.
  • Applied Biosystems
  • Bio-Rad Laboratories, Inc.
  • Caribou Biosciences, Inc.
  • Cellectis SA
  • CRISPR Therapeutics AG
  • Editas Medicine, Inc.
  • GenScript Biotech Corporation
  • Integrated DNA Technologies, Inc.
  • Intellia Therapeutics, Inc.
  • Lonza Group AG
  • Merck & Co., Inc.
  • Merck Group
  • New England Biolabs, Inc.
  • Roche Holding AG
  • Sangamo Therapeutics, Inc.
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
  • Zymo Research Corporation

Related Topics

Related Reports

Synthetic Biology Market - Global Forecast 2026-2032 - Product Image

Synthetic Biology Market - Global Forecast 2026-2032

  • Report
  • 189 Pages
  • Global
From
DNA Fragments Market - Global Forecast 2026-2032 - Product Image

DNA Fragments Market - Global Forecast 2026-2032

  • Report
  • 192 Pages
  • Global
From
Synthetic Biology Healthcare Applications Market - Strategic Insights and Forecasts (2026-2031) - Product Image

Synthetic Biology Healthcare Applications Market - Strategic Insights and Forecasts (2026-2031)

  • Report
  • 156 Pages
  • Global
From
Microarray Analysis - Global Strategic Business Report - Product Image

Microarray Analysis - Global Strategic Business Report

  • Report
  • 192 Pages
  • Global
From
Competent Cells Market Report 2026 - Product Image

Competent Cells Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.